Inventor · disambiguated record
John Yeoman
Also filed as: YEOMAN JOHN
4 granted patents·4 pending applications·22 citations·filing 2018–2023
76Inventor score
Top patents by PatentIndex Score
8 records- 0196US11299479B1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Apr 12, 2022·8 cites·23 claims
- 0296US10899746B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Jan 26, 2021·5 cites·27 claims
- 0394US11780826B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2022·Granted Oct 10, 2023·2 cites·19 claims
- 0493US10723720B2Bisamide sarcomere activating compounds and uses therofAMGEN INC·Filed 2018·Granted Jul 28, 2020·7 cites·21 claims
- 0583US2024158372A1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 0661US2025215030A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 0760US2025215029A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 0858US2025179103A16-oxodecahydropyrrolo[1,2-a][1,5]diazocine and 6-oxodecahydro-4h-pyrrolo[2,1-d][1,5]thiazocine derivatives as stat3 and stat6 modulators for the treatment of cancer and inflammatory conditionsRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Yeoman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →